Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2019-04-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
监事会关于公司终止实施2017年度限制性股票股权激励计划并回购注销已授予但尚未解锁限制性股票相关事项的核查意见
Regulatory Filings
2019-04-28 Chinese
2018年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2018年度募集资金存放与实际使用情况的专项报告" which translates to "2018 Annual Special Report on the Deposit and Actual Use of Raised Funds." It details the amount of funds raised through a non-public stock issuance, the management and use of these funds, compliance with regulatory requirements from the China Securities Regulatory Commission and Shanghai Stock Exchange, and includes audit and sponsor verification reports. The document includes detailed financial figures on the raised funds, their usage, and management, as well as attachments with verification opinions from an accounting firm and a securities company. This is a specialized report focused on the management and use of capital raised by the company, which aligns with the category of Capital/Financing Update (CAP). It is not a full annual report (10-K), nor an earnings release or audit report. It is a detailed report on fundraising and capital usage, not merely an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2019-04-28 Chinese
关于使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 金宇生物技术股份有限公司 regarding the use of idle self-owned funds for cash management, including details about the investment amount, types of financial products, risk control measures, and board approval. It is a formal disclosure about financing activities but does not contain financial statements or results. The document is relatively short (1773 characters) and serves as a notification of a financing decision rather than a full financial report. Therefore, it fits best under Capital/Financing Update (CAP).
2019-04-28 Chinese
关于终止实施2017年度限制性股票股权激励计划并回购注销已授予但尚未解锁限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from a company regarding the termination of its 2017 restricted stock incentive plan and the repurchase and cancellation of granted but unvested restricted shares. It details the number of shares involved, repurchase prices, board and independent director approvals, legal opinions, and the impact on share capital structure. The content focuses on share repurchase and cancellation related to an equity incentive plan, including detailed figures and procedural compliance. This fits the category of a Transaction in Own Shares (POS) because it reports the company's buyback and cancellation of its own shares under a stock incentive plan. It is not a full financial report, earnings release, or management report, nor is it a regulatory filing or announcement of a report publication. The document length and detail confirm it is the actual announcement of the transaction, not just a brief notice or certification.
2019-04-28 Chinese
关于董事会、监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and nomination of the company's board of directors and supervisory board members. It details the candidates for the new board and supervisory board, their qualifications, and the process of nomination and election. It references the upcoming shareholder meeting for approval but does not contain financial data or financial results. The document is a formal announcement about changes in the company's board and supervisory committee, which fits the category of Board/Management Information (MANG). The document length is 3790 characters, which is relatively short but contains substantive information about board changes, not just a brief notice or report publication announcement. Therefore, the appropriate classification is MANG with high confidence.
2019-04-28 Chinese
董事会工作条例（2019年4月修订）
Governance Information Classification · 100% confidence The document is titled '董事会工作条例' which translates to 'Board of Directors Work Rules' or 'Board of Directors Regulations'. It details the structure, duties, meeting procedures, and governance of the company's board of directors. It includes sections on board composition, director qualifications, meeting convocations, voting procedures, and responsibilities. There is no financial data, earnings information, or report publication mentioned. The content is focused on governance practices and internal rules of the board. Therefore, this document fits the category of Governance Information (CGR).
2019-04-28 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.